CCP
ABMD

Corient Capital Partners’s Abiomed Inc ABMD Stock Holding History

Corient Capital Partners’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1.31M Buy
5,298
+15
+0.3% +$4.05K 0.1% 172
2022
Q2 		$1.31M Buy
5,283
+1,430
+37% +$386K 0.1% 180
2022
Q1 		$1.28M Buy
3,853
+3,163
+458% +$974K 0.08% 208
2021
Q4 		$248K Buy
690
+17
+3% +$5.74K 0.02% 593
2021
Q3 		$219K Buy
+673
New +$228K 0.02% 609

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Corient Capital Partners's ABMD Position: Q3 2022 in Review

Corient Capital Partners increased its Abiomed Inc (ABMD) stake by 0.28% in Q3 2022, buying an estimated $4.05K and bringing the position to 5,298 shares worth $1.31M. The position accounts for 0.1% of the portfolio, ranked #172.

Corient Capital Partners first reported a position in ABMD in Q3 2021 and has held it in 5 quarters since. 517 funds tracked by Wall St. Rank hold ABMD as of Q3 2022.

  • Corient Capital Partners held 5,298 shares of Abiomed Inc worth $1.31M as of Q3 2022.
  • Corient Capital Partners bought 15 Abiomed Inc shares in Q3 2022, an estimated $4.05K.
  • Abiomed Inc made up 0.1% of Corient Capital Partners's portfolio in Q3 2022, its #172 holding.
  • Corient Capital Partners first reported a position in Abiomed Inc in Q3 2021 and has held it in 5 quarters since.
  • 517 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.